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Objective 
 
Mitochondrial DNA (mtDNA) mutations can cause a wide range of severe diseases and are 
maternally inherited. Due to the lack of curative therapy, different strategies to prevent 
transmission of the mutation carrying mtDNA are being analyzed. One of these is the 
application of pronuclear transfer (PNT) to healthy cytoplasm.  
 
Design 
 
In this study, the potential of PNT was assessed in mice by measuring the mtDNA carry-over 
in pre-implantation embryos. 
 
Materials and Methods 
 
Pronuclei from zygotes of B6D2/F1 mouse were transplanted into enucleated NZB/OlaHsd 
mouse zygotes and vice versa to determine the quantity of mtDNA carried over in 
reconstructed zygotes as well as in individual blastomeres.  
The mtDNA carry-over was determined by restriction fragment length polymorphism (RFLP) 
analysis. 
 
Results 
 
Mean percentage of mtDNA carry-over in reconstructed zygotes and blastomeres was 1.26 
(±1.83)% and 0.94 (±1.39)%, respectively. The carry-over range was similar in the 
reconstructed zygotes and blastomeres with a minimal carry-over of 0% and a maximal carry-
over of 4.47%. In 10 out of 17 samples, no mtDNA carry-over was detected (Table 1).  
 
 
 
 
 
 
 
 
 
 
 
Celltype after PNT N  mtDNA carry-over (%) Mean (±SD) (%)  
1 3.09 
2 0 
3 0 
4 0 
5 1.28 
6 0 
 
 
 
Reconstructed zygotes  
(n = 7) 
7 4.47 
 
 
 
 
1.26 (±1.83) 
1 0 
2 0 
0 
1 1.52 
2 0 
0.76 (±1.08) 
1 0 
2 1.73 
0.86 (±1.22) 
1 4.08 
2 0 
2.04 (±2.89) 
1 0 
 
 
 
 
2-cell embryos 
(n = 5 times 2) 
2 2.08 
1.04 (±1.47) 
 
Table 1: mtDNA carry-over (in %) in reconstructed zygotes and blastomeres after PNT in mice (Zygotes 1-6: PNT from B6D2 to NZB 
mouse; zygote 7: PNT from NZB to B6D2 mouse; all blastomeres from 2-cell embryos are PNT from B6D2 to NZB mouse) 
 
Conclusions 
 
Our data show that there is almost no or minimal mtDNA carry-over after PNT. This 
technique could potentially be used to prevent transmission of mtDNA mutation disorders 
from mothers to their offspring, providing hope for diseased parents to fulfil their desire of 
conceiving healthy babies. 
 
Support 
 
This Research was funded by a PhD grant and a postdoctoral grant from the Special Research 
Foundation (BOF) of Ghent University, Belgium, awarded to J.N. and M.V., respectively. 
P.D.S. is the holder of a fundamental clinical research mandate by the Flemish foundation of 
scientific research (FWO-Vlaanderen). 
 
